Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $592.10M≈ (+$40M≈)
- Previous value:
- $552.09M≈
- # of changes:
- 24
- New positions:
- 0
- Reported for:
- 31 Dec 2016 (Q4)
- Latest filing date:
- 31 Jan 2017
Kahn Brothers Group has disclosed a total of 24 changes to the portfolio in the (2016 Q4) SEC report(s): increased the number of shares of 5 and decreased the number of shares of 19 position(s).
What stocks did Kahn Brothers Group buy in 2016 Q4?
In the 2016 Q4 report(s) the following changes have been made to the top investments: (C) Citigroup Inc (reduced shares -1.77%), (MRK) Merck & Company Inc (reduced shares -0.55%), (NYT) New York Times Company (reduced shares -0.25%), (BP) BP PLC-SPONS ADR (added shares +0.43%) and (HOLX) Hologic Inc (reduced shares -3.01%).
24 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GlaxoSmithKline PLC ADR
|
+31.85%
|
$48.14
|
+7.23%($51.62)
|
5.42%
|
2014 Q3
|
≈ 2.50 years
|
||||
|
|
VOXX International Corp
|
+1.01%
|
$4.70
|
|
1.39%
|
2013 Q2 or earlier
|
≈ 3.75+ years
|
||||
|
|
MBIA Inc
|
+0.53%
|
$10.70
|
-50.75%($5.27)
|
7.89%
|
2013 Q2 or earlier
|
≈ 3.75+ years
|
||||
|
|
BP PLC-SPONS ADR
|
+0.43%
|
$37.38
|
+13.96%($42.60)
|
8.27%
|
2013 Q2 or earlier
|
≈ 3.75+ years
|
||||
|
|
BlackBerry Ltd
|
+0.29%
|
$6.89
|
+29.10%($8.90)
|
5.07%
|
2013 Q3
|
≈ 3.50 years
|
||||
|
|
Genie Energy Ltd
|
-0.10%
|
$5.75
|
+145.48%($14.12)
|
0.39%
|
2013 Q2 or earlier
|
≈ 3.75+ years
|
||||
|
|
Straight Path Communications Inc
|
-0.23%
|
$33.91
|
|
1.22%
|
2013 Q3
|
≈ 3.50 years
|
||||
|
|
New York Times Company
|
-0.25%
|
$13.30
|
+468.12%($75.56)
|
8.38%
|
2013 Q2 or earlier
|
≈ 3.75+ years
|
||||
|
|
IDW Media Holdings Inc
|
-0.48%
|
$49.99
|
-34.89%($32.55)
|
0.66%
|
2015 Q3
|
≈ 1.50 years
|
||||
|
|
Merck & Company Inc
|
-0.55%
|
$58.87
|
+118.96%($128.90)
|
9.47%
|
2013 Q2 or earlier
|
≈ 3.75+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.